Bank & Trust CO Gilead Sciences, Inc. Transaction History
Bank & Trust CO
- $123 Billion
- Q3 2024
A detailed history of Bank & Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank & Trust CO holds 5,965 shares of GILD stock, worth $529,811. This represents 0.41% of its overall portfolio holdings.
Number of Shares
5,965
Previous 6,000
0.58%
Holding current value
$529,811
Previous $412 Million
21.49%
% of portfolio
0.41%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,895Shares Held
1.02BCall Options Held
12MPut Options Held
9.02M-
Black Rock Inc. New York, NY121MShares$10.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.77 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.37 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.27 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $111B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...